Khalilur Rahman (second from right), President of the eighty-first session of the United Nations General Assembly, chairs the High-level Meeting on Pandemic Prevention, Preparedness and Response. Credit: UN Photo/Mark Garten

By Shreya Komar
UNITED NATIONS, Sep 30 2026 (IPS)

The United Nations High-level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) on September 25 called for faster and more sustained investment in pandemic preparedness. Speakers emphasized that future outbreaks will require coordinated action across governments, health systems, and communities.

The meeting, held three years after the General Assembly’s first high-level meeting on pandemic preparedness, focused on lessons from COVID-19 and persistent gaps in global health security.

“No country can protect itself alone,” UN Deputy Secretary-General Amina J. Mohammed said, underscoring the need to turn the lessons of COVID-19 into long-term preparedness.

Opening the meeting, Dr. Khalilur Rahman, President of the General Assembly, highlighted three priorities: closing financing gaps, adopting a stronger “One Health” approach, and ensuring equitable access to vaccines, diagnostics, therapeutics and other essential medical tools.

“All countries need and deserve well-funded community-based systems for detection, surveillance, communication and containment,” Rahman said, calling for predictable and sustainable financing. He also stressed that pandemic preparedness must address the links between human, animal and environmental health, arguing that stronger understanding of these interactions could help prevent outbreaks from reaching human populations. Equitable access to life-saving tools, he said, is both a matter of justice and a critical component of containing outbreaks.

In a press briefing held on the same day, World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus warned that global investment in health security has declined since the acute phase of the COVID-19 pandemic, reviving what he described as a cycle of “panic and neglect.”

Although countries and international institutions have established new mechanisms for pandemic preparedness, Tedros said the scale and speed of investment remain insufficient.

The WHO has launched and supported a range of initiatives since the pandemic, including the Pandemic Fund, strengthened pandemic and epidemic intelligence, vaccine and medical countermeasure initiatives, the mRNA Technology Transfer Programme, the WHO BioHub System and the Global Health Emergency Corps.

Countries have also strengthened the international framework governing pandemic response. In 2024, WHO member states adopted amendments to the International Health Regulations, while the WHO Pandemic Agreement was adopted the following year.

However, recent outbreaks, including Ebola in the Democratic Republic of the Congo, have underscored the continuing risk of infectious diseases crossing borders and becoming international threats. Tedros said the possibility of a future respiratory pandemic remains particularly concerning because of the potential scale of its impact.

A key issue still under negotiation is the Pathogen Access and Benefit Sharing (PABS) system, which is intended to establish arrangements for sharing pathogen materials and information while ensuring that countries providing those resources benefit from vaccines, diagnostics and other products developed from them.

Tedros urged countries to conclude the negotiations. “So today, I leave you with just one request: get PABS done as soon as possible. Please conclude the negotiations as soon as possible,” he said. “We are as strong as our weakest link.”

He also emphasized the importance of investing in countries more vulnerable to pandemics, not as an act of charity, but rather as collective action against the common goal of pandemic prevention. Sustained financing and stronger international cooperation will be central to preventing future outbreaks from becoming global emergencies.

IPS UN Bureau Report

Participants at the fourth UN High-Level Meeting on the Prevention of Noncommunicable Diseases and Mental Health (NCDs), held in September 2025. Credit: UN Photo/Eric Kanalstein

By Shreya Komar
UNITED NATIONS, Sep 25 2026 (IPS)

On September 21, just prior to the opening of the United Nations General Assembly Debate (UNGA81), the NCD Alliance held its fifth Multi-stakeholder Gathering, “Strategies for a Sustainable NCD and Mental Health Response,” during the UN High-level Week.

“This meeting may be on the sidelines of the UN General Assembly, but the issues discussed here are central to the global health agenda,” emphasized Mary-Ann Etiebet, President and CEO of Vital Strategies and moderator of the event. She opened by highlighting the continuing global burden of noncommunicable diseases (NCDs) and the gap in funding and resources dedicated to addressing it.

The discussion centered on how countries can sovereignly lead, scale, sustain and strengthen their responses, with a particular emphasis on country ownership and “putting the country in the driver’s seat”.

The gathering focused on how countries can move from policy commitments to implementation and build sustainable responses to NCDs and mental health through governance, financing, and cross-sector partnerships.

Fleming Kondradsen, a panelist and Chief Scientific Officer at Novo Nordisk Foundation, emphasized the importance of supporting more horizontal approaches to health. Rather than creating parallel systems and new structures, he argued for strengthening and integrating NCD prevention and care into existing health systems wherever possible.

For Paula Johns, another panelist from Brazil and Executive Director of ACT Health Promotion Brazil, meaningful participation begins with a fundamental question: How do we include the public in public health? Maintaining strong relationships with communities, she argued, is essential to ensuring that health policies and interventions reflect the realities of the people they are intended to serve.

Johns also raised concerns about the growing pressures affecting young people in Brazil, describing a “mental health global pandemic”. Among the issues she highlighted were social media and sports betting, calling for greater attention and regulation of environments that can affect young people’s health and wellbeing.

The discussion reinforced the importance of looking beyond the health sector itself. Addressing NCDs and mental health requires collaboration across government, civil society, communities and other sectors that shape the environments in which people live.

For Prisca Githuka, founder of the Pink Hearts Cancer Support Foundation from Nairobi, Kenya, one of the most important questions when it comes to addressing NCDs and mental health is meaningfully engaging people with lived experience. Consulting people who have experienced a disease, she said, is only the beginning. Meaningful engagement means involving people with lived experience in co-creating solutions and participating directly in decision-making structures. This distinction, she noted, separates genuine participation from tokenism.

People with lived experience should not simply be invited to share their stories. They should have a meaningful role in shaping decisions that impact their health, and their contributions should be fairly compensated. Githuka also stressed the importance of measuring whether people’s input actually influences outcomes. Engagement should not end when feedback is collected. Instead, stakeholders should ask: What changed as a result of that feedback? And did the final implementation actually benefit the people with lived experience?

Her own advocacy work has included petitions and efforts to secure funding and support for cancer patients, including advocacy around oncology packages and the National Health Insurance Fund.

The emphasis on advocating for lived experience at the forefront of decision-making also highlighted the impact of smaller organizations and community-based groups. For many of these organizations, their most important contribution is their proximity to the communities affected by NCDs and mental health conditions. Their stories can provide insight into gaps that may not be visible in national strategies or global commitments.

For people with lived experience with NCDs and mental health conditions, being in the room is only the first step. The measure of meaningful engagement is whether they have a voice in decisions, whether that voice influences what happens next, and whether the resulting policies and services improve their lives.

IPS UN Bureau Report

WHO team visits the pediatric oncology ward at the King Hussein Cancer Centre in Amman, Jordan. November 2025. Credit: WHO

By Shreya Komar
UNITED NATIONS, Sep 18 2026 (IPS)

When a child is diagnosed with cancer, their chances of survival should not depend on where they live, yet according to the WHO, more than 80 percent of children with cancer in high-income countries are cured, compared with fewer than 30 percent in many low- and middle-income countries (LMICs).

The key gap lies in access to available medicines. In East Africa, hospitals report frequent stockouts of essential chemotherapy agents, with shortages affecting 32–49 percent of critical medicines such as methotrexate and etoposide. Survival therefore depends less on the discovery of new therapies and more on whether children are able to access and complete uninterrupted treatment.

“No child should be denied a chance of survival because the medicines they need are unavailable, unaffordable, or out of reach,” affirmed Dr Carlos Rodriguez-Galindo, Executive Vice President of St. Jude Children’s Research Hospital.

In efforts to combat this issue and in honor of Childhood Cancer Awareness Month, the World Health Organization (WHO) and its collaborators at the Global Platform for Access to Childhood Cancer Medicines published a new strategy report with a roadmap to strengthen the global market and improve the circulation of childhood cancer medicines in many LMICs.

Each year, an estimated 400,000 children develop cancer. Unlike many adult cancers, childhood cancer is generally not preventable. As a result, the most effective strategy for improving outcomes is to ensure that children receive a prompt and accurate diagnosis, followed by effective, evidence-based treatment and tailored supportive care.

The report highlighted many key barriers LMICs face when implementing this strategy. First, the supply of essential childhood cancer medicines is unreliable and depends on a small number of manufacturers, especially for medicines that meet international quality standards.

Secondly, LMICs often buy small amounts of cancer medicines, making supply less reliable and prices higher due to perceived low demand. Limited government funding and poor planning can also lead to shortages. Cancer medicines may take years to become available in LMICs because of slow approval processes. There is little investment in medicines designed specifically for children, especially for low-resource settings. This is partly because childhood cancer affects fewer people, making it a smaller market for companies.

“Persistent market challenges continue to affect access for children, and it is critical that we continue to work together to enhance the reliability and affordability of childhood cancer medicines,” said Dr. Kennedy Lishimpi, Permanent Secretary for Technical Services, Ministry of Health, Zambia.

Most types of childhood cancer can be cured with widely available generic medicines and other forms of treatment, including surgery and radiotherapy. Yet children in LMICs often face significant barriers to accessing these lifesaving interventions. Lower survival rates are driven by delays in diagnosis, difficulties obtaining an accurate diagnosis, limited access to appropriate therapy, treatment abandonment, death from treatment-related toxicity, and avoidable relapse.

Improving access to childhood cancer care, including essential medicines and technologies, has the potential to improve survival across all income settings.

The report also mentions how cost of treatment was another big barrier to care. In some cases, More than 70 percent of children being treated for leukaemia stop or do not complete their cancer treatment due to financial reasons.

The Global Platform prioritized a set of ten interventions in the report that will be implemented over 2026-2030. These included working more closely with medicine companies, increasing the number of reliable suppliers, speeding up medicine approval, improving planning and purchasing, and strengthening access to affordable, quality-assured childhood cancer medicines. The interventions also focused on supporting research, improving price information, including these medicines in national health coverage, and encouraging the development of new treatments.

“Rather than focusing only on individual products or prices, market shaping interventions aim to strengthen overall market health by improving the conditions required for sustainable access,” the report states.

In practice, this could look like integrating childhood cancer medications into national health benefit packages. For example, in 2024, Nepal declared free treatment for children with cancer at public health facilities.

“Where the price is more friendly, there are plenty of suppliers; that’s sort of the goal we’re trying to reach,” said Rongrong Liu, program manager from St. Jude’s global operations.

Additionally, the report also mentions that voluntary licensing could play an important role in improving access to new childhood cancer medicines in LMICs by allowing other quality-assured manufacturers to produce medicines that are still protected by patents. This could increase the number of suppliers, improve competition, lower prices, and help medicines reach LMICs sooner, reducing delays caused by high costs or dependence on a single manufacturer. The Global Platform plans to work with companies that own these medicines to negotiate licensing agreements for priority medicines. These agreements would allow selected manufacturers to produce and supply the medicines in LMICs under agreed conditions.

“At the beginning, we have focused only on clinical forecast, but in reality there are a lot of logistical parameters that we need to consider,” said Alessio Mola, pharmacist at WHO, emphasizing the importance of the proposed market strategies.

The newly launched roadmap provides good guidance on strengthening child cancer medicine markets and supply systems and is an essential step toward closing the survival gap and ensuring that where a child is born does not determine whether they survive cancer.

IPS UN Bureau Report

On 2 September 2026, UNICEF staff and partners are distributing recreation kits at Child-Friendly Spaces (CFS) at the holding center for children affected by the recent flash floods in Nuwakot District, Bagmati Province, Nepal. Credit: UNICEF/Laxmi Prasad Ngakhusi

By Shreya Komar
UNITED NATIONS, Sep 11 2026 (IPS)

Two weeks after devastating floods struck Nepal, communities across the country are still struggling to meet basic needs as humanitarian efforts continue. The disaster, triggered by a glacial collapse, has become one of Nepal’s deadliest in recent years, leaving widespread destruction in its wake.

As of Wednesday, 1,367 people had been confirmed dead, while 5,132 remained missing, including 587 foreign nationals. 13,646 people have been rescued, but many families are still waiting for news about their loved ones. Search operations remain ongoing, including efforts to reach people who may still be trapped in tunnels and other difficult-to-access areas.

The scale of the destruction has made delivering aid particularly challenging. Floodwaters have damaged homes, roads, bridges, and other essential infrastructure, leaving some communities isolated. The Nepalese government has been using military helicopters to drop aid into areas that remain difficult to reach, while temporary bridges are also being constructed to reconnect communities that have received insufficient assistance.

Families urgently need food, clean drinking water, shelter and access to healthcare. Health services are particularly important for vulnerable groups, including an estimated 1,600 pregnant women who are expected to give birth soon. Ensuring that these women can reach medical facilities and receive appropriate prenatal and emergency care is a major concern.

Mental health support is another pressing need that could become increasingly important as the immediate emergency begins to subside. Survivors have lost homes, livelihoods and, in many cases, family members.

On Wednesday September 9, UN Resident Coordinator for Nepal Lila Pieters Yahia, briefed reporters at UN Headquarters on the ongoing humanitarian efforts by the UN and the Nepalese government.

“People were just so depressed,” Yahia reflected after her visit to the affected communities.

Many people are also coping with the uncertainty of not knowing whether missing relatives are alive. Reuniting separated families and children has therefore become another important part of the humanitarian response.

The United Nations and its humanitarian partners launched a USD 49.6 million flash appeal last Friday to provide life-saving assistance to people affected by the disaster. The appeal is intended to support critical needs including food, clean water, logistics and other immediate relief. So far, approximately USD 22 million has been pledged, leaving a significant funding gap.

The Nepal Red Cross Society is leading much of the humanitarian response, with support from the International Federation of Red Cross and Red Crescent Societies, the International Committee of the Red Cross and other humanitarian organizations. Aid is being distributed through a combination of government agencies, community organizations and non-governmental organizations. However, humanitarian officials continue to warn that access remains one of the greatest obstacles to reaching people in need.

Yahia described the destruction as an example of the increasingly severe losses faced by countries vulnerable to climate change. “The devastation Nepal has experienced is an extraordinary, stark illustration of the losses and damages that climate-vulnerable countries are increasingly facing,” she said.

Nepal’s experience has also renewed calls for greater international action on climate change and climate justice. As a mountainous country particularly vulnerable to changing weather patterns and the effects of a warming climate, Nepal faces a disproportionate burden.

Despite the enormous challenges, Yahia says aid is reaching many affected communities, and survivors continue to demonstrate hope. “People are still searching for family members they know they may never find,” she said, highlighting the resilience keeping people strong. Yet thousands of people remain in need, and the destruction of transportation networks means that reaching the most isolated communities will take time.

“My plea tonight to the international community: we need to demonstrate solidarity with the people of Nepal,” Yahia emphasized.

For Nepal, the emergency is far from over. The immediate priority remains saving lives and providing food, water, shelter and access to healthcare. As communities begin the long process of rebuilding, the country will also need sustained international support to recover from one of its most destructive disasters.

IPS UN Bureau Report

Children accompanied by their mothers receive routine vaccinations during a vaccination session at the Bunia health center in Ituri province in the Democratic Republic of Congo.

By Shreya Komar
UNITED NATIONS, Sep 4 2026 (IPS)

While Uganda announced the end of its Ebola outbreak last week, the Democratic Republic of Congo (DRC) continues to battle its deadliest Ebola outbreak to date. As of September 1st, there have been over 6,000 cases, including over 3,000 deaths, with Ituri standing as the most affected province.

In a post on X on September 2, Tedros Adhanom Ghebreyesus, Director-General for the World Health Organization (WHO) expressed his concern that most deaths were still occurring in communities rather than in treatment centres, and among people who were not known contacts. This implies that there may be several methods of transmission that are unknown and several underreported cases.

“Until every chain is broken, the epidemic will continue to pose a threat to the DRC, its neighbours and the region as a whole,” said Dr. Tedros.

The outbreak has spread substantially, and with continued transmission, high mortality, and an urgent need to reduce preventable deaths, there have been talks of using the Ervebo® vaccine, the only currently licensed Ebola vaccine available, to treat patients. The vaccine was licensed and prequalified by the WHO in 2019 for the prevention of Ebola virus disease caused by Ebola virus (EBOV) in individuals aged one year or older. This vaccine, however, is not licensed for use against Bundibugyo virus (BDBV), and therefore the use of Ervebo® against BDBV would be considered off-label use for the current virus.

The Bundibugyo virus (BDBV), which is causing the current outbreak, differs from the last outbreak caused by the Ebola virus (EBOV). BDBV and EBOV cause Ebola disease that is clinically similar but are different in the genetic material they contain. Although the vaccine is highly effective against EBOV, the WHO said it remains unknown how much the immunity provided by the approved vaccine protects against the virus causing the current outbreak (BDBV).

In its most recent published emergency guidance on the use of Ervebo®, the WHO has concluded that evidence available to date remains insufficient to support the programmatic use of Ervebo® for the prevention of BDBV disease, and the vaccine should only be used within the context of a research protocol.

The WHO recommends testing Ervebo® vaccine in a carefully run trial to determine whether it protects against BDBV. During a serious outbreak, wider use may be considered, but only as part of research with a clear safety plan. They emphasized that communities should be told that vaccination does not replace proven outbreak-control measures.

Additionally, there has been promising progress in efforts to create targeted treatments against the new virus variant. “Two new vaccines against Bundibugyo virus are now in safety trials in the UK and Canada,” Dr. Tedros told reporters in Geneva on Wednesday. He announced that the phase 1 clinical trials are being held by the U.S.-based Moderna group using mRNA technology, and another by the University of Oxford.

IPS UN Bureau Report

Follow @IPSNewsUNBureau

UN Secretary-General António Guterres (at podium) briefs reporters on the status of the Ebola virus outbreak. Credit: UN Photo/Mark Garten

By Shreya Komar
UNITED NATIONS, Aug 28 2026 (IPS)

Following 42 consecutive days without a new confirmed case, The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) have announced the end of the Ebola outbreak in Uganda.

The outbreak began in the Democratic Republic of the Congo (DRC) and Uganda in May and was caused by a rare strain of the Ebola virus known as the Bundibugyo species. There are no approved vaccines or therapeutics against the Bundibugyo strain, though several are currently being trialed in the DRC, Canada, and the United Kingdom. The virus is highly contagious and can still be transmitted after an infected person has died.

Uganda’s last patient, whose infection was imported, was discharged from care on 16 July 2026, and no new cases have been reported since.

“Uganda has shown that Ebola can be stopped when leadership acts decisively, communities are trusted and public health systems reach people quickly,” said H.E. Dr Jean Kaseya, Director-General of Africa CDC.

“The outbreak is the fastest-growing Ebola epidemic on record. It is growing faster and wider than the response to contain it. But it can be stopped,” said UN Secretary-General António Guterres during a press stakeout on August 27. Guterres referenced the recently-appointed UN Senior Ebola Coordinator, Julien Harneis, who is working with regional partners to strengthen community engagement, surveillance, treatment, safe burials and measures to contain the virus. The UN is also reinforcing preparedness and coordination with South Sudan and the Central African Republic to prevent further cross-border transmission.

Additionally, to address the challenge of limited health infrastructure and laboratory services, the WHO, with funding support from the African Development Bank (AfDB), has handed over a Truck-Mounted Mobile Biosafety Level 3 Laboratory to the Government of Uganda in efforts to strengthen Uganda’s public health response capacity and support post-outbreak preparedness.

The mobile laboratory will support rapid, field-based diagnostic testing during outbreaks, reducing the time required to transport samples to centralized testing facilities and accelerating public health decision-making. The laboratory is expected to improve access to testing in hard-to-reach areas and at outbreak epicenters, where timely diagnosis is critical to containing disease transmission.

Contrary to Uganda, in the DRC, the devastation of the Ebola outbreak continues to what has now become the country’s deadliest public health crisis. As of August 25th, 5,713 cases have been confirmed, claiming 2,744 lives. About 500 new cases are being reported every week, with women and children being severely affected.

Emmanuel Kalinde, Child Protection Manager in Ituri, said the crisis had upended children’s lives, leaving many to grieve loved ones while facing conflict and displacement. He stressed that sustained support was essential to help them heal and regain hope.

The WHO continues to advise against travel and trade restrictions related to Ebola outbreaks. However, despite potential risks, they do not recommend suspending flights, closing borders, or denying entry to travellers from affected countries.

IPS UN Bureau Report

Follow @IPSNews
  

Strong health systems start with midwives. Credit: Unsplash

By Shreya Komar
UNITED NATIONS, Aug 15 2025 (IPS)

Asia-Pacific’s midwives are a healthcare lifeline capable of delivering nearly 90 percent of essential maternal and newborn services. Yet the region grapples with severe shortages, underinvestment, and systemic neglect.

The newly released State of Asia’s Midwifery 2024 Report, released by the United Nations Population Fund (UNFPA), reveals that despite midwives’ lifesaving potential, many countries lack enough workers, face poor training and support systems, and struggle with weak policy backing. The findings underscore an urgent need to elevate midwives from auxiliary roles to central pillars of health systems across the region.

Drawing on data from 21 countries in the UNFPA Asia-Pacific (AP) region, the report was intended to assist countries in the region to meet the challenges of the health-related SDGs and the Every Woman Every Newborn Everywhere (EWENE) agenda, a global initiative focused on accelerating the reduction of preventable maternal and newborn deaths.

The report shows hundreds of thousands of maternal and newborn deaths in 2023 across the Asia-Pacific that timely midwife interventions could have largely prevented. The region faces a shortage of approximately 200,000 midwives, contributing to an annual toll of roughly 66,000 maternal deaths alone. These stark figures expose both the human cost and the systemic failure to invest in this essential healthcare workforce.

According to the report, at least five Asia-Pacific countries, including Lao PDR, Mongolia, Pakistan, Papua New Guinea (PNG) and Timor-Leste, are estimated to face needs-based midwife shortages, with Pakistan and PNG experiencing the most severe gaps.

The report projects that Pakistan and PNG will still face shortages by 2030, even if they maintain current rates of midwife graduation and full employment. Other countries, such as Afghanistan, Myanmar, and Viet Nam, are also likely to experience ongoing shortages; however, limited data prevents precise estimates of these shortages.

Beyond shortages, the report points to alarming gaps in education quality, regulatory frameworks, and leadership pathways for midwives. Many countries still struggle with limited pre-service training, scarce continuing education opportunities, weak licensing systems, and fragmented governance. Retention suffers as poor pay, inadequate infrastructure, and lack of professional recognition push midwives away, especially from rural and underserved areas.

The report also emphasizes how placing midwives in leadership roles can strengthen decision-making on policies that directly affect maternal and newborn health, improve supervision and mentoring, and ensure midwifery perspectives shape regulation, training, and service delivery.

Countries like Afghanistan, Iran, and Malaysia show how midwife-led governance can integrate professional expertise into national health strategies, ultimately enhancing the quality, reach, and effectiveness of sexual, reproductive, maternal, newborn and adolescent health (SRMNAH) services.

Since 2021, nine countries have increased midwife availability (Bangladesh, Cambodia, Iran, Lao PDR, Maldives, Nepal, PNG, Sri Lanka and Viet Nam), four have seen decreases (Indonesia, Malaysia, Pakistan and the Philippines), and two show no significant change (Mongolia and Timor-Leste). It shows that while some nations are making progress, regional gains are uneven, and shortages can worsen without sustained investment and retention strategies.

The WHO estimates that countries with fewer than 25 doctors, nurses and midwives per 10,000 people will struggle to provide adequate primary healthcare, a threshold that, while general, offers a benchmark for minimum workforce density.

Acting on this information is imperative because midwives are the most cost-effective, accessible answer to achieving safe motherhood and newborn survival goals. As the World Health Organization notes, when well-trained and integrated, midwives can address roughly 90 percent of essential reproductive and newborn health needs. Still, the world faces a global shortfall of nearly 900,000 midwives, and many in Asia endure poor working conditions, low pay, and limited career paths. Thus, saving lives demands investing in midwifery education, fair compensation, regulation, leadership, and full integration into health systems.

Midwife supervisor Arafin Mim, who oversees a team serving over 32,500 Rohingya refugees on the remote island of Bhasan Char in Bangladesh, captures the importance of her work simply.

“I feel this profession from the corner of my heart. It’s about making a connection with a pregnant woman, building a relationship during her pregnancy.”

Mim’s dedication illustrates the commitment and resilience midwives bring to some of the world’s most challenging environments.

In UNFPA’s recent opinion piece, the Regional Director Pio Smith shares a vivid image of midwives delivering in remote Bangladesh during climate crises to describe their resilience.

“When non-stop rain caused flooding in her village, the maternity ward, pharmacy, and storage room were submerged by water. She still continued to deliver babies, without electricity, even supporting emergency cesarean sections as needed with the doctors on call.”

The report urges governments and partners to close needs-based midwife shortages by expanding education in line with ICM standards, improving faculty and curricula, and ensuring equitable deployment. It recommends updating policies so midwives can work to their full scope, using data-driven workforce planning to create sanctioned posts, and adopting fair recruitment, deployment, and retention strategies.

Finally, it calls for empowering midwives with leadership roles in SRMNAH governance, regulation, and service improvement.

UNFPA’s Executive Director, Dr. Natalia Kanem, reminds us in a statement that “midwives are instrumental to navigating these challenges: They can provide up to 90 percent of essential services for sexual and reproductive health and bring their expertise and counsel to women wherever they are.”

Country examples such as Bangladesh, Nepal, and Cambodia offer hopeful signs. Bangladesh’s midwife-led birthing centers, Nepal’s rural midwifery deployments, and Cambodia’s regulatory reforms are exemplary, but much more action and investment are needed.

Midwives must be valued and supported as key professionals with quality education, fair pay, robust licensing, leadership opportunities, and a seat at health policymaking tables. This will result in fewer maternal and infant deaths, stronger newborn health, and more resilient healthcare systems.

IPS UN Bureau Report

Follow @IPSNewsUNBureau
  

The origin of COVID-19 remains a mystery, hampered by secrecy, stalled research and global inaction.

By Shreya Komar
UNITED NATIONS, Aug 14 2025 (IPS)

More than four years since Covid-19 upended the world, the question of how it began remains unanswered. Did SARS-CoV-2 originate from animals to humans naturally, or did it accidentally escape from a laboratory? The World Health Organization’s latest report offers little new clarity and raises serious concerns about international cooperation and scientific transparency. On June 27, 2025, the WHO Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) released its second report examining how the virus emerged. Despite years of work and renewed international focus, the findings have been widely criticized for failing to break new ground. Much of the blame lies in what wasn’t included. Critical data requested from China was never provided, leaving glaring holes in the investigation.

“The report adds almost nothing to what a few talented independent investigators found several years ago,” said Viscount Ridley, co-author of Viral: The Search for the Origin of Covid-19.

“That it has taken five years and 23 people to produce this ‘all but useless’ addition to the literature on the origin of Covid-19 is frankly a disgrace.”

The search for COVID-19’s origin is not simply an academic exercise. Understanding how this virus entered the human population is crucial for preventing the next pandemic. Scientists agree that future coronavirus outbreaks are not only possible but also likely. Knowing whether SARS-CoV-2 came from a wildlife market or a laboratory accident informs how humanity prepares for the next spillover.

While the SAGO report acknowledges both the zoonotic spillover and lab-leak theories as plausible, it stresses the need for further evidence. That evidence remains frustratingly out of reach.

“If China had been transparent all along, we would have been able to pinpoint what happened,” said Dr. Deborah Birx, who served as the White House Coronavirus Response Coordinator from 2020 to 2021.

Most virologists continue to believe that the virus has a natural origin, a view reinforced in a new documentary titled “Unmasking COVID-19’s True Origins” released by Real Stories on July 15. “The vast majority of virologists understand the virus had a natural origin,” one expert says in the film. Still, without access to early samples and full records, both theories remain scientifically viable, and political tensions continue to cloud the inquiry.

This latest WHO report comes just weeks after a major development in global health policy. On May 20, 2025, the World Health Assembly adopted the long-anticipated WHO Pandemic Agreement, a legally binding treaty intended to strengthen preparedness for future outbreaks. The agreement aims to fix the deep weaknesses revealed by the COVID-19 pandemic: sluggish coordination, delayed data sharing, and unequal access to vaccines and treatments.

The treaty commits countries to share information on emerging pathogens faster, to improve cooperation on disease surveillance, and to distribute medical tools like vaccines more equitably. It also respects national sovereignty, meaning that countries will not be forced to relinquish control of their public health decisions. Still, some provisions, particularly those concerning the sharing of pathogen samples and related benefits, remain under negotiation and are expected to be finalized in 2026.

The WHO’s first SAGO report, released on June 9, 2022, also found that both leading origin theories were possible and called for further data from Chinese authorities. The absence of transparency since then has only hardened frustration among scientists. The call for cooperation is not just about this virus but about preparing for what comes next.

Meanwhile, research vital to fighting COVID-19 and future respiratory diseases has quietly stalled. In 2024, Ohio State University was awarded USD 15 million to study new treatments for SARS-CoV-2 and long COVID. One promising clinical trial focused on a drug to treat hypoxemic respiratory failure, a leading cause of death among hospitalized patients. But halfway through, the National Institutes of Health abruptly terminated the funding.

The cancellation saved USD 500,000 but came after USD 1.5 million had already been spent. As a result, researchers were forced to abandon the trial entirely, delaying possible treatments that could have helped the nearly one million people hospitalized annually for respiratory failure caused by COVID, flu, and other infections. “This is a disaster for all of us,” said a veteran scientist at Ohio State.

“We’re all depressed and living on a knife-edge, because we know we could lose the rest of our grants any day. These people really hate us, yet all we’ve done is work hard to make people’s health better. A flu pandemic is coming for us; what’s happening in cattle is truly scary and all we have is oxygen and hope for people.”

Scientific leaders argue that the world must do the opposite of what is currently happening: invest more, not less, in pandemic-related science. Research that has languished or been underfunded must be revived and expanded. More international partnerships are needed, especially with researchers in hotspot regions such as China, to ensure the global community is better equipped to face the next threat.

As the WHO itself notes, “The work to understand the origins of SARS-CoV-2 remains unfinished.”

But without transparency, funding, and political will, it may remain that way for years to come. And if that happens, the world could be left just as vulnerable when the next pandemic emerges.
IPS UN Bureau Report

Follow @IPSNewsUNBureau
  

Leaders, policymakers, and partners unite at Africa Day 2025. Credit: Shreya Komar/IPS

By Shreya Komar
UNITED NATIONS, Jul 30 2025 (IPS)

Africa is making progress on over two-thirds of the Sustainable Development Goals (SDGs), but the pace remains far too slow to meet the 2030 targets, especially in areas like decent employment, gender equality, and access to social protection.

This was the central warning of the newly released Africa Sustainable Development Report (ASDR), launched during the 2025 Africa Day session at the UN’s High-Level Political Forum.

The report, which tracks alignment between the African Union’s Agenda 2063 and the UN’s 2030 Agenda, offers a sobering yet actionable picture: Africa’s development efforts are gaining traction, but deep structural barriers, ranging from inadequate financing and data gaps to high youth unemployment and gender-based exclusion, continue to stall momentum.

Despite being home to several of the world’s fastest-growing economies, the continent faces an annual sustainable development financing gap of up to USD 762 billion, according to the report. Social protection coverage remains alarmingly low, with only 19 percent of vulnerable populations benefiting from any form of safety net. Public investment in social protection across most African countries is below 3 percent of GDP, significantly under the global average.

“The current pace of progress is insufficient to achieve the SDGs by 2030,” the report warns, prompting leaders to explore actionable strategies for scaling up inclusive growth, regional integration, and institutional capacity building across the continent.

Health outcomes have improved in areas like life expectancy and disease control, but maternal mortality and unequal access to care persist. Gender equality remains constrained by legal barriers, high rates of violence, and the burden of unpaid care work.

On SDG 8, the continent struggles with low productivity, informality, and youth unemployment, emphasizing the need for inclusive job creation and economic transformation. While the continent has seen some recovery in sectors like tourism, key indicators such as GDP growth per capita (down from 2.7 percent in 2021 to 0.7 percent in 2023) and youth employment remain weak. Over 23 percent of African youth are not in education, employment, or training (NEET), with women disproportionately affected. Despite its potential, tourism contributed just 6.8 percent to GDP in 2023.

Economic shocks, climate change, and geopolitical instability continue to undermine job creation and sustainable growth. The report calls for data-driven strategies, innovative financing, and integrated policies to bridge development gaps and build resilient, equitable systems aligned with both global and continental agendas.

“It is not enough to just create jobs, but we must ensure safe working conditions,” said H.E. Amb. Selma Malika Haddadi, Deputy Chairperson of the African Union Commission.

UN Deputy Secretary-General Amina Mohammed acknowledged the uneven starting point for African countries, stating, “too often, Africa isn’t at the table where decisions are made but is the first to feel the impact.” She added, “Our young people deserve more than we give them,” highlighting the pressing need for inclusive investment in youth education.

Central to the discussion was the need to mobilize greater technical and financial support, scale up climate financing, tackle illicit financial flows, and reduce social and economic inequalities. Participants emphasized stronger partnerships (SDG 17), inclusive social protection systems, and youth- and women-led innovation as key enablers for transformational change. The launch of the ASDR marked a major milestone, offering data-driven insights to support national strategies.

IPS UN Bureau Report

Follow @IPSNewsUNBureau
  

A child receives treatment at a cholera clinic in the DRC, where clean water is scarce and healthcare even scarcer. Credit: UNICEF

By Shreya Komar
UNITED NATIONS, Jul 14 2025 (IPS)

The Democratic Republic of Congo (DRC) is grappling with one of its worst cholera outbreaks in recent history, exposing deep systemic cracks in public health, water infrastructure, and humanitarian response, leaving its youngest citizens in peril.

On April 3, 2025, the United Nations released a stark warning: a fast-spreading cholera outbreak in the southern province of Tanganyika was placing thousands at grave risk. As of that date, 9 out of 11 health zones in the province were affected, with over 1,450 confirmed cases and 27 deaths, marking a six-fold increase compared to the previous year.

By early June, the outbreak had exploded far beyond Tanganyika. The World Health Organization (WHO) reported 29,392 suspected cholera cases and 620 deaths nationwide, making this the worst outbreak in the country in six years. Most alarmingly, children, especially those under five, are dying in disproportionate numbers due to weakened immune systems, chronic malnutrition, and an almost total collapse of access to clean water and sanitation in many areas.

A recent Instagram post from the WHO underscored the scale of response efforts: “To tackle the rise in #cholera cases & deaths in #DRCongo, WHO is mobilizing resources for the hardest-hit areas: emergency beds, free medical care, and deployment of over 7,000 community health workers.”

Cholera is an acute diarrheal infection caused by ingesting food or water contaminated with the Vibrio cholerae bacterium. It is entirely preventable and highly treatable. So why is it still killing hundreds in a single outbreak?

“The reason cholera has persisted is that we have not addressed poverty to the level that we should,” said Dr. Anita Zaidi, director of the Enteric and Diarrheal Diseases program at the Gates Foundation.

The answer lies not in the biology of the disease, but in the fragile reality of life in the eastern DRC. In provinces like Tanganyika, North Kivu, and South Kivu already scarred by decades of armed conflict, mass displacement, and collapsing infrastructure the cholera bacterium finds ideal conditions to spread.

A 2024 study on cholera risk in Goma found that the lack of water infrastructure forced communities to rely on unsafe sources like Lake Kivu, the small Lake Vert, and the Mubambiro River, which are often contaminated with human waste.

In the most affected areas, only 20 percent of residents have access to safe drinking water. Healthcare infrastructure is threadbare, with limited beds, medicine, or trained personnel to handle waves of acute cases. Years of humanitarian funding cuts have only made the situation worse especially for women and children.

Between July 2024 and June 2025, nearly 4.5 million children under five are expected to suffer from acute malnutrition in the DRC, 1.4 million of whom are experiencing severe acute malnutrition. Cholera, which causes rapid dehydration and can be fatal within hours, is especially deadly in malnourished children. With their immune systems already compromised, even the smallest lapse in hydration or care can become fatal.

Still, field efforts are outpaced by the scale of the emergency. In 2017, the Global Task Force on Cholera Control (GTFCC) launched the “Ending Cholera: A Global Roadmap to 2030”, which aimed to eliminate the disease from 20 countries, including the DRC.

The strategy emphasized early detection, integrated prevention (clean water, sanitation, vaccination), and international coordination. But with only five years left before 2030, the roadmap’s vision is faltering in the DRC. In 2023, the DRC recommitted to cholera elimination, as documented by the WHO, but outbreaks have only worsened.

A Doctors Without Borders emergency response in Lomera, South Kivu, highlights the impact of unmanaged gold rushes, poor sanitation, and overburdened clinics creating a perfect storm for cholera transmission.

Efforts by the UN and NGOs have ramped up in recent months. Oral Cholera Vaccines (OCVs) are being deployed in hotspots. Emergency treatment centers are being established. Supplies are arriving, albeit slowly. But a true resolution requires structural investments in safe water infrastructure, consistent access to healthcare, and conflict stabilization.

More importantly, child-focused solutions must be prioritized. In a recent peer-reviewed article, Congolese researcher Aymar Akilimali called for dedicated pediatric cholera wards in eastern DRC, noting that most children have no access to tailored emergency care even during active outbreaks.

He also stated that “a community-based and multisectoral response must be implemented, including an anti cholera vaccination campaign, a budgeted response plan with involved partners, as well as the development of national cholera control plans, epidemiological surveillance, risk communication on cholera, community awareness, and social mobilization.”

The cholera outbreak in the DRC is not just a public health crisis; it is a humanitarian failure. It is a warning signal of what happens when decades of conflict, poverty, and weak governance go unaddressed. As 2030 approaches, the question isn’t whether we can end cholera, it’s whether we’re willing to invest in the lives of those most at risk of it.

IPS UN Bureau Report

Follow @IPSNewsUNBureau